Skip to main content
NCBI home page
Gut logoLink to Gut
. 1995 Jun;36(6):922–926. doi: 10.1136/gut.36.6.922

Increased PiZ gene frequency for alpha 1 antitrypsin in patients with genetic haemochromatosis.

A N Elzouki 1, R Hultcrantz 1, P Stål 1, R Befrits 1, S Eriksson 1
PMCID: PMC1382634  PMID: 7615285

Abstract

The putative relationship between genetic haemochromatosis and PiZ alpha 1 antitrypsin deficiency was studied using a monoclonal antibody against the PiZ variant in 67 consecutive patients with genetic haemochromatosis seen at Karolinska Hospital and Huddinge University Hospital, Stockholm over a 10 year period. Three (4.5%) of the patients with haemochromatosis were found to be PiZ homozygotes (odds ratio = 82, confidence interval = 26, 256; p < 0.0001). The prevalence of the heterozygous (PiZ) phenotype was similar to that in the general population (p = 0.937). During the ascertainment period, liver biopsy was performed in 65 (97%) of the patients; 66% (2 of 3) of the PiZ homozygotes were found to have cirrhosis compared with 10% (6/59) of the non-carriers of the PiZ variant (p = 0.039). None of the homozygous or heterozygous alpha 1 antitrypsin deficient patients had developed hepatocellular carcinoma compared with 3.4% (2 of 59) of the non-PiZ gene carriers (p = 1.0). Two of those with the homozygous phenotype had developed severe emphysema. HLA typing was performed in 18 patients, 16 (89%) of whom manifested antigens known to be linked to haemochromatosis. There were no significant differences between the PiZ gene carriers and non-carriers in mean age at onset of disease, sex distribution, or HLA type. Two of the PiZ heterozygotes had plasma alpha 1 antitrypsin concentrations below the normal range, though the group mean was lower than that of the non-PiZ carriers (p = 0.0003). The data suggest that the presence of the PiZ allele for alpha1 antitrypsin deficiency, in a double dose, is associated with genetic haemochromatosis and may contribute to the earlier onset of cirrhosis in these patients, though it does not increase the risk of hepatocellular carcinoma.

Full text

PDF
922

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand S., Schade R. R., Bendetti C., Kelly R., Rabin B. S., Krause J., Starzl T. E., Iwatsuki S., Van Thiel D. H. Idiopathic hemochromotosis and alpha-1-antitrypsin deficiency: coexistence in a family with progressive liver disease in the proband. Hepatology. 1983 Sep-Oct;3(5):714–718. doi: 10.1002/hep.1840030515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bacon B. R., Park C. H., Brittenham G. M., O'Neill R., Tavill A. S. Hepatic mitochondrial oxidative metabolism in rats with chronic dietary iron overload. Hepatology. 1985 Sep-Oct;5(5):789–797. doi: 10.1002/hep.1840050514. [DOI] [PubMed] [Google Scholar]
  3. Bassett M. L., Halliday J. W., Powell L. W. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 1986 Jan-Feb;6(1):24–29. doi: 10.1002/hep.1840060106. [DOI] [PubMed] [Google Scholar]
  4. Berg N. O., Eriksson S. Liver disease in adults with alpha-1 -antitrypsin deficiency. N Engl J Med. 1972 Dec 21;287(25):1264–1267. doi: 10.1056/NEJM197212212872502. [DOI] [PubMed] [Google Scholar]
  5. Brantly M., Nukiwa T., Crystal R. G. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med. 1988 Jun 24;84(6A):13–31. doi: 10.1016/0002-9343(88)90154-4. [DOI] [PubMed] [Google Scholar]
  6. Carlson J. A., Rogers B. B., Sifers R. N., Finegold M. J., Clift S. M., DeMayo F. J., Bullock D. W., Woo S. L. Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest. 1989 Apr;83(4):1183–1190. doi: 10.1172/JCI113999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Crowley J. J., Sharp H. L., Freier E., Ishak K. G., Schow P. Fatal liver disease associated with alpha 1-antitrypsin deficiency PiM1/PiMduarte. Gastroenterology. 1987 Aug;93(2):242–244. doi: 10.1016/0016-5085(87)91008-0. [DOI] [PubMed] [Google Scholar]
  8. Edwards C. Q., Griffen L. M., Kushner J. P. Southern blood club symposium: an update on selected aspects of hemochromatosis. Am J Med Sci. 1990 Oct;300(4):245–250. doi: 10.1097/00000441-199010000-00009. [DOI] [PubMed] [Google Scholar]
  9. Eriksson S. Alpha 1-antitrypsin deficiency and liver cirrhosis in adults. An analysis of 35 Swedish autopsied cases. Acta Med Scand. 1987;221(5):461–467. [PubMed] [Google Scholar]
  10. Eriksson S., Carlson J., Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med. 1986 Mar 20;314(12):736–739. doi: 10.1056/NEJM198603203141202. [DOI] [PubMed] [Google Scholar]
  11. Eriksson S., Lindmark B., Hanik L. A Swedish family with alpha 1-antitrypsin deficiency, haemochromatosis, haemoglobinopathy D and early death in liver cirrhosis. J Hepatol. 1986;2(1):65–72. doi: 10.1016/s0168-8278(86)80009-5. [DOI] [PubMed] [Google Scholar]
  12. Eriksson S., Lindmark B., Olsson S. Lack of association between hemochromatosis and alpha-antitrypsin deficiency. Acta Med Scand. 1986;219(3):291–294. doi: 10.1111/j.0954-6820.1986.tb03313.x. [DOI] [PubMed] [Google Scholar]
  13. Hallberg L., Björn-Rasmussen E., Jungner I. Prevalence of hereditary haemochromatosis in two Swedish urban areas. J Intern Med. 1989 Apr;225(4):249–255. doi: 10.1111/j.1365-2796.1989.tb00074.x. [DOI] [PubMed] [Google Scholar]
  14. Hultcrantz R., Glaumann H. Studies on the rat liver following iron overload: biochemical studies after iron mobilization. Lab Invest. 1982 Apr;46(4):383–392. [PubMed] [Google Scholar]
  15. Hultcrantz R., Mengarelli S. Ultrastructural liver pathology in patients with minimal liver disease and alpha 1-antitrypsin deficiency: a comparison between heterozygous and homozygous patients. Hepatology. 1984 Sep-Oct;4(5):937–945. doi: 10.1002/hep.1840040526. [DOI] [PubMed] [Google Scholar]
  16. Jeppsson J. O., Laurell C. B., Fagerhol M. Properties of isolated human alpha1-antitrypsins of Pi types M, S and Z. Eur J Biochem. 1978 Feb 1;83(1):143–153. doi: 10.1111/j.1432-1033.1978.tb12078.x. [DOI] [PubMed] [Google Scholar]
  17. Kaserbacher R., Propst T., Propst A., Graziadei I., Judmaier G., Vogel W. Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis. Hepatology. 1993 Sep;18(3):707–708. [PubMed] [Google Scholar]
  18. Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
  19. Lindmark B., Eriksson S. Regional differences in the idiopathic hemochromatosis gene frequency in Sweden. Acta Med Scand. 1985;218(3):299–304. doi: 10.1111/j.0954-6820.1985.tb06128.x. [DOI] [PubMed] [Google Scholar]
  20. Loebermann H., Tokuoka R., Deisenhofer J., Huber R. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol. 1984 Aug 15;177(3):531–557. [PubMed] [Google Scholar]
  21. McCracken A. A., Kruse K. B., Brown J. L. Molecular basis for defective secretion of the Z variant of human alpha-1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342. Mol Cell Biol. 1989 Apr;9(4):1406–1414. doi: 10.1128/mcb.9.4.1406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Perlmutter D. H. The cellular basis for liver injury in alpha 1-antitrypsin deficiency. Hepatology. 1991 Jan;13(1):172–185. [PubMed] [Google Scholar]
  23. RIGAS D. A., FINCH S. C. Electrophoretic studies of serum proteins in hemochromatosis. Am J Med Sci. 1959 May;237(5):566–574. doi: 10.1097/00000441-195905000-00003. [DOI] [PubMed] [Google Scholar]
  24. Rabinovitz M., Gavaler J. S., Kelly R. H., Van Thiel D. H. Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis. Hepatology. 1992 Jul;16(1):145–148. doi: 10.1002/hep.1840160124. [DOI] [PubMed] [Google Scholar]
  25. Simon M., Fauchet R., Hespel J. P., Beaumont C., Brissot P., Hery B., Hita De Nercy Y., Genetet B., Bourel M. Idiopathic hemochromatosis: a study of biochemical expression in 247 heterozygous members of 63 families: evidence for a single major HLA-linked gene. Gastroenterology. 1980 Apr;78(4):703–708. [PubMed] [Google Scholar]
  26. Stremmel W., Riedel H. D., Niederau C., Strohmeyer G. Pathogenesis of genetic haemochromatosis. Eur J Clin Invest. 1993 Jun;23(6):321–329. doi: 10.1111/j.1365-2362.1993.tb02031.x. [DOI] [PubMed] [Google Scholar]
  27. Summers K. M., Halliday J. W., Powell L. W. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology. 1990 Jul;12(1):20–25. doi: 10.1002/hep.1840120105. [DOI] [PubMed] [Google Scholar]
  28. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976 Jun 10;294(24):1316–1321. doi: 10.1056/NEJM197606102942404. [DOI] [PubMed] [Google Scholar]
  29. Terasaki P. I., Bernoco D., Park M. S., Ozturk G., Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol. 1978 Feb;69(2):103–120. doi: 10.1093/ajcp/69.2.103. [DOI] [PubMed] [Google Scholar]
  30. Wallmark A., Alm R., Eriksson S. Monoclonal antibody specific for the mutant PiZ alpha 1-antitrypsin and its application in an ELISA procedure for identification of PiZ gene carriers. Proc Natl Acad Sci U S A. 1984 Sep;81(18):5690–5693. doi: 10.1073/pnas.81.18.5690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Williams H. L., Johnson D. J., Haut M. J. Simultaneous spectrophotometry of Fe2+ and Cu2+ in serum denatured with guanidine hydrochloride. Clin Chem. 1977 Feb;23(2 Pt 1):237–240. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES